Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

47747

	registered interest
	date	08/04/2014
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what estimate they have made of the number of cats deliberately poisoned by antifreeze products each year; and what action they are taking to combat such attacks.
	tabling member printed	Lord Black of Brentwood
	uin	HL6695
	answer	answer is ministerial correction date of answer 10/04/2014 answer text <p> </p><p>The Government has not made any estimate of the number of cats deliberately poisoned by antifreeze products. Any deliberate poisoning of a cat is an offence under the Animal Welfare Act 2006 punishable by a fine of £20,000 and/or six months imprisonment.</p><p> </p> answering member printed Lord De Mauley question first answered 10/04/2014 12:00:00 answering member 2202 label Biography information for Lord De Mauley
	tabling member	4171 label Biography information for Lord Black of Brentwood

61517

	registered interest
	date	11/06/2014
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	hansard heading	Eurostar
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they have received any representations about the refusal of Eurostar to allow pets on board its trains using the Passports for Pets scheme.
	tabling member printed	Lord Black of Brentwood
	uin	HL295
	answer	answer is ministerial correction date of answer 23/06/2014 answer text <p> </p><p>Defra has received a small number of letters from pet owners on this issue since 2012.</p><p> </p><p> </p><p> </p><p>Government does not impose any obligation on transport companies to carry pet animals. It is a commercial decision on the part of transport companies as to whether they offer this service to their customers.</p><p> </p> answering member printed Lord De Mauley question first answered 23/06/2014 11:04:34 answering member 2202 label Biography information for Lord De Mauley
	tabling member	4171 label Biography information for Lord Black of Brentwood

61516

	registered interest
	date	11/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Homosexuality
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the Written Answer by Earl Howe on 6 May (WA 358), whether they are considering introducing legislation to prevent the practice of reparative or conversion therapy on homosexual men and women.
	tabling member printed	Lord Black of Brentwood
	uin	HL294
	answer	answer is ministerial correction date of answer 25/06/2014 answer text <p>This Government does not believe that being lesbian, gay or bisexual is an illness to be treated or cured. We have no current plans to ban or restrict conversion therapy via legislation as we do not feel this would be an effective preventive measure.</p><p> </p><p>We do, however, fully recognise the importance of this issue. Therefore, the Minister of State for Care and Support, Norman Lamb, convened a roundtable with professional bodies and charities in February of this year to discuss collaborative measures to help prevent the use of such therapies. The Department continues to work with these organisations.</p><p> </p> answering member printed Earl Howe question first answered 25/06/2014 16:32:04 answering member 2000 label Biography information for Earl Howe
	tabling member	4171 label Biography information for Lord Black of Brentwood

64120

	registered interest
	date	25/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Anticoagulants
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many people in England are treated with (1) warfarin, and (2) novel oral anticoagulants each year.
	tabling member printed	Lord Black of Brentwood
	uin	HL624
	answer	answer is ministerial correction date of answer 01/07/2014 answer text <p>Information is not held centrally on the number of people treated with warfarin or novel oral anticoagulants. The following table provides information on the number of prescription items written in England and dispensed in the community in the United Kingdom, for the latest calendar year, for apixaban, dabigatran etexilate, rivaroxaban, and warfarin sodium.</p><p> </p><table><tbody><tr><td colspan="2"><p>Prescription items written in England and dispensed in the community in the United Kingdom for 2013 <sup>1</sup></p></td></tr><tr><td><p>Medicine <sup>2</sup></p></td><td><p>Items (000s)</p></td></tr><tr><td><p>Apixaban</p></td><td><p>14.4</p></td></tr><tr><td><p>Dabigatran etexilate</p></td><td><p>174.0</p></td></tr><tr><td><p>Rivaroxaban</p></td><td><p>190.0</p></td></tr><tr><td><p>Warfarin sodium <sup>3</sup></p></td><td><p>11,022.8</p></td></tr><tr><td><p>Total for apixaban, dabigatran etexilate, rivaroxaban, and warfarin sodium</p></td><td><p>11,401.2</p></td></tr><tr><td><p>Percentage of warfarin sodium compared to the total for apixaban, dabigatran etexilate, rivaroxaban, and warfarin sodium</p></td><td><p>96.7%</p></td></tr></tbody></table><p><em> </em></p><p><em>Source:</em> ePACT and Hospital ePACT, NHS Prescription Services, part of the NHS Business Services Authority</p><p><em> </em></p><p><em>Notes:</em></p><p><sup>1. </sup>The figures include prescriptions written in a hospital in England but dispensed in the community in the United Kingdom.</p><p><sup>2. </sup>These medicines are also used in secondary care, however no equivalent measure to a prescription item is available for secondary care data.</p><p>Some patients treated with warfarin may receive prescription items for two or three different strengths of warfarin to allow the dose to be altered in response to monitoring of INR. (NB: warfarin is available as 0.5mg, 1mg, 3mg and 5mg tablets).</p> answering member printed Earl Howe grouped question UIN HL625 question first answered 01/07/2014 11:46:45 answering member 2000 label Biography information for Earl Howe
	tabling member	4171 label Biography information for Lord Black of Brentwood

64121

	registered interest
	date	25/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Anticoagulants
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what percentage of the total number of prescriptive items for apixaban, dabigatran etexilate, rivaroxaban, and warfarin sodium in England were for warfarin sodium in the last year for which figures are available.
	tabling member printed	Lord Black of Brentwood
	uin	HL625
	answer	answer is ministerial correction date of answer 01/07/2014 answer text <p>Information is not held centrally on the number of people treated with warfarin or novel oral anticoagulants. The following table provides information on the number of prescription items written in England and dispensed in the community in the United Kingdom, for the latest calendar year, for apixaban, dabigatran etexilate, rivaroxaban, and warfarin sodium.</p><p> </p><table><tbody><tr><td colspan="2"><p>Prescription items written in England and dispensed in the community in the United Kingdom for 2013 <sup>1</sup></p></td></tr><tr><td><p>Medicine <sup>2</sup></p></td><td><p>Items (000s)</p></td></tr><tr><td><p>Apixaban</p></td><td><p>14.4</p></td></tr><tr><td><p>Dabigatran etexilate</p></td><td><p>174.0</p></td></tr><tr><td><p>Rivaroxaban</p></td><td><p>190.0</p></td></tr><tr><td><p>Warfarin sodium <sup>3</sup></p></td><td><p>11,022.8</p></td></tr><tr><td><p>Total for apixaban, dabigatran etexilate, rivaroxaban, and warfarin sodium</p></td><td><p>11,401.2</p></td></tr><tr><td><p>Percentage of warfarin sodium compared to the total for apixaban, dabigatran etexilate, rivaroxaban, and warfarin sodium</p></td><td><p>96.7%</p></td></tr></tbody></table><p><em> </em></p><p><em>Source:</em> ePACT and Hospital ePACT, NHS Prescription Services, part of the NHS Business Services Authority</p><p><em> </em></p><p><em>Notes:</em></p><p><sup>1. </sup>The figures include prescriptions written in a hospital in England but dispensed in the community in the United Kingdom.</p><p><sup>2. </sup>These medicines are also used in secondary care, however no equivalent measure to a prescription item is available for secondary care data.</p><p>Some patients treated with warfarin may receive prescription items for two or three different strengths of warfarin to allow the dose to be altered in response to monitoring of INR. (NB: warfarin is available as 0.5mg, 1mg, 3mg and 5mg tablets).</p> answering member printed Earl Howe grouped question UIN HL624 question first answered 01/07/2014 11:46:44 answering member 2000 label Biography information for Earl Howe
	tabling member	4171 label Biography information for Lord Black of Brentwood

64122

	registered interest
	date	25/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Anticoagulants
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what action they are taking to increase the uptake of novel oral anticoagulants in the management of atrial fibrillation.
	tabling member printed	Lord Black of Brentwood
	uin	HL626
	answer	answer is ministerial correction date of answer 01/07/2014 answer text <p>Decisions on the prescribing of medicines are a matter for clinicians in discussion with their patients.</p><p> </p><p>National Health Service commissioners are legally required by regulations to fund those anticoagulant treatments recommended by the National Institute for Health and Care Excellence(NICE) in its technology appraisal guidance.</p><p> </p><p>The NICE Implementation Collaborative published a consensus statement on supporting the use of novel oral anticoagulants in non-valvular atrial fibrillation on 18 June 2014. This is available at:</p><p> </p><p>www.nice.org.uk/resource/CG180/pdf/c/cg180-atrial-fibrillation-nic-consensus-statement-on-the-use-of-noacs?id=gvyb3hjdqrcjtn6ytpwx3ydb64</p><p> </p><p>NICE published its updated clinical guideline on the management of atrial fibrillation on 25 June 2014 which recommends that novel oral anticoagulants should be offered where appropriate.</p><p> </p><p>The latest data from the Innovation Scorecard show that uptake of new anticoagulants across England is increasing. Further information is available at:</p><p> </p><p>www.hscic.gov.uk/catalogue/PUB13669</p><p> </p> answering member printed Earl Howe question first answered 01/07/2014 11:47:28 answering member 2000 label Biography information for Earl Howe
	tabling member	4171 label Biography information for Lord Black of Brentwood

64118

	registered interest
	date	25/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Heart Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what action they are taking to improve the diagnosis of atrial fibrillation.
	tabling member printed	Lord Black of Brentwood
	uin	HL622
	answer	answer is ministerial correction date of answer 08/07/2014 answer text <p>NHS England is taking a number of actions to improve the care and management of people with atrial fibrillation (AF). It has published <em>Our Ambition to Reduce Premature Mortality: A resource to support commissioners in setting a level of ambition</em>, which identifies improved management of AF as a priority for reducing premature mortality. The resource can be found at:</p><p> </p><p>www.england.nhs.uk/ourwork/sop/red-prem-mort/</p><p> </p><p>National Health Service Improving Quality's <em>Living Longer Lives</em> programme includes promoting the use of a simple but effective audit tool called Guidance on Risk Assessment and Stroke Prevention for Atrial Fibrillation (GRASP-AF) which simplifies the process of identifying patients with AF who are not receiving the right treatment. NHS Improving Quality is currently collaborating with partner organisations, including charities, to support the nationwide roll-out of GRASP-AF.</p><p> </p><p>This work will be supported by the publication of an economic analysis commissioned by NHS Improving Quality using GRASP data which demonstrates both the current and potential impact of atrial fibrillation management on the number of AF related strokes.</p><p><em> </em></p><p>Discussions are also underway to consider whether opportunistic testing for atrial fibrillation (AF) should be encouraged nationally as part of the NHS Health Check programme.</p><p> </p> answering member printed Earl Howe grouped question UIN HL623 question first answered 08/07/2014 15:27:07 answering member 2000 label Biography information for Earl Howe
	tabling member	4171 label Biography information for Lord Black of Brentwood

64119

	registered interest
	date	25/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Heart Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, in the light of the publication of the National Institute for Health and Care Excellence clinical guideline 180, what action they are taking to ensure appropriate risk stratification and uptake of anti-thrombotic therapy among patients with atrial fibrillation.
	tabling member printed	Lord Black of Brentwood
	uin	HL623
	answer	answer is ministerial correction date of answer 08/07/2014 answer text <p>NHS England is taking a number of actions to improve the care and management of people with atrial fibrillation (AF). It has published <em>Our Ambition to Reduce Premature Mortality: A resource to support commissioners in setting a level of ambition</em>, which identifies improved management of AF as a priority for reducing premature mortality. The resource can be found at:</p><p> </p><p>www.england.nhs.uk/ourwork/sop/red-prem-mort/</p><p> </p><p>National Health Service Improving Quality's <em>Living Longer Lives</em> programme includes promoting the use of a simple but effective audit tool called Guidance on Risk Assessment and Stroke Prevention for Atrial Fibrillation (GRASP-AF) which simplifies the process of identifying patients with AF who are not receiving the right treatment. NHS Improving Quality is currently collaborating with partner organisations, including charities, to support the nationwide roll-out of GRASP-AF.</p><p> </p><p>This work will be supported by the publication of an economic analysis commissioned by NHS Improving Quality using GRASP data which demonstrates both the current and potential impact of atrial fibrillation management on the number of AF related strokes.</p><p><em> </em></p><p>Discussions are also underway to consider whether opportunistic testing for atrial fibrillation (AF) should be encouraged nationally as part of the NHS Health Check programme.</p><p> </p> answering member printed Earl Howe grouped question UIN HL622 question first answered 08/07/2014 15:27:07 answering member 2000 label Biography information for Earl Howe
	tabling member	4171 label Biography information for Lord Black of Brentwood

79518

	registered interest
	date	22/07/2014
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	hansard heading	Pet Travel Scheme
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the effectiveness of the Pet Travel Scheme in allowing owners to take dogs and cats abroad.
	tabling member printed	Lord Black of Brentwood
	uin	HL1417
	answer	answer is ministerial correction date of answer 28/07/2014 answer text <p> </p><p>The European Union (EU) pet travel scheme (Regulation (EC) No. 998/2003) has made it easier and cheaper for pet owners to travel with their pets and return to the UK. Under the EU scheme pet dogs, cats and ferrets can enter the UK from any country in the world without the need for quarantine providing they meet the strict requirements for entry for the part of the world they are travelling from.</p><p> </p> answering member printed Lord De Mauley question first answered 28/07/2014 11:53:14 answering member 2202 label Biography information for Lord De Mauley
	tabling member	4171 label Biography information for Lord Black of Brentwood

79519

	registered interest
	date	22/07/2014
	answering body	Department for Education
	answering dept id	60
	answering dept short name	Education
	answering dept sort name	Education
	hansard heading	Department for Education
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what arrangements they have in place to assess the performance of the Department for Education Board overall, and of its individual members.
	tabling member printed	Lord Black of Brentwood
	uin	HL1418
	answer	answer is ministerial correction date of answer 28/07/2014 answer text <p>The Department for Education Board is assessed through a board effectiveness evaluation carried out in accordance with the Code of Good Practice of Corporate Governance in Central Government Departments, published in 2011 by HM Treasury and the Cabinet Office.</p><p> </p> answering member printed Lord Nash question first answered 28/07/2014 11:56:35 answering member 4270 label Biography information for Lord Nash
	tabling member	4171 label Biography information for Lord Black of Brentwood